Back to Journals » Drug Design, Development and Therapy » Volume 11
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,477 | Dovepress* | 8,542+ | 1,044 | 9,586 | |
PubMed Central* | 935 | 322 | 1,257 | ||
Totals | 9,477 | 1,366 | 10,843 | ||
*Since 15 November 2017 |
View citations on PubMed and Google Scholar